Department of Microbiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Department of Microbiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
J Mol Biol. 2024 Aug 15;436(16):168651. doi: 10.1016/j.jmb.2024.168651. Epub 2024 Jun 10.
In Escherichia coli, many environmental stressors trigger polyphosphate (polyP) synthesis by polyphosphate kinase (PPK1), including heat, nutrient restriction, toxic compounds, and osmotic imbalances. PPK1 is essential for virulence in many pathogens and has been the target of multiple screens for small molecule inhibitors that might serve as new anti-virulence drugs. However, the mechanisms by which PPK1 activity and polyP synthesis are regulated are poorly understood. Our previous attempts to uncover PPK1 regulatory elements resulted in the discovery of PPK1* mutants, which accumulate more polyP in vivo, but do not produce more in vitro. In attempting to further characterize these mutant enzymes, we discovered that the most commonly-used PPK1 purification method - Ni-affinity chromatography using a C-terminal poly-histidine tag - altered intrinsic aspects of the PPK1 enzyme, including specific activity, oligomeric state, and kinetic values. We developed an alternative purification strategy using a C-terminal C-tag which did not have these effects. Using this strategy, we were able to demonstrate major differences in the in vitro response of PPK1 to 5-aminosalicylic acid, a known PPK1 inhibitor, and observed several key differences between the wild-type and PPK1* enzymes, including changes in oligomeric distribution, increased enzymatic activity, and increased resistance to both product (ADP) and substrate (ATP) inhibition, that help to explain their in vivo effects. Importantly, our results indicate that the C-terminal poly-histidine tag is inappropriate for purification of PPK1, and that any in vitro studies or inhibitor screens performed with such tags need to be reconsidered in that light.
在大肠杆菌中,许多环境胁迫因素通过多磷酸盐激酶(PPK1)触发多磷酸盐(polyP)的合成,包括热、营养限制、有毒化合物和渗透失衡。PPK1 是许多病原体毒力所必需的,并且已经成为多种小分子抑制剂的靶点筛选,这些抑制剂可能成为新的抗毒力药物。然而,PPK1 活性和多磷酸盐合成的调节机制还知之甚少。我们之前试图揭示 PPK1 调节元件的尝试导致了 PPK1突变体的发现,这些突变体在体内积累了更多的多磷酸盐,但在体外却没有产生更多的多磷酸盐。在试图进一步表征这些突变酶时,我们发现最常用的 PPK1 纯化方法——使用 C 末端多组氨酸标签的 Ni 亲和层析——改变了 PPK1 酶的固有特性,包括比活、寡聚状态和动力学值。我们开发了一种使用 C 末端 C 标签的替代纯化策略,该策略没有这些影响。使用这种策略,我们能够证明 PPK1 对 5-氨基水杨酸(一种已知的 PPK1 抑制剂)的体外反应存在显著差异,并观察到野生型和 PPK1酶之间的几个关键差异,包括寡聚分布的变化、酶活性的增加以及对产物(ADP)和底物(ATP)抑制的增加抗性,这有助于解释它们的体内效应。重要的是,我们的结果表明,C 末端多组氨酸标签不适合 PPK1 的纯化,并且任何使用这种标签进行的体外研究或抑制剂筛选都需要重新考虑这一点。